Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1334 participants.
Also called NCT02389946
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,334 participants
- Sponsor
- Registry
-
NCT02389946
-
- Main results
- Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial
- Other papers using this trial's data
- Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients
- Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents
- Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization: 3-Year Outcomes From the Randomized BIOFLOW V Trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Belgium, Canada, Denmark, Germany, Hungary, Israel, Netherlands, New Zealand, South Korea, Spain, Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT02389946. Randomized; single masking; primary purpose treatment. Start 2015-05 (registry gives no type); primary completion 2017-04 (actual). Results posted on 2019-08-01.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
- Acronym
- BIOFLOW-V
- Condition
- Coronary Artery Disease
- Condition
- Atherosclerosis, Coronary
- Condition
- Myocardial Ischemia
- Condition
- Ischemic Heart Disease
- Condition
- Acute Coronary Syndrome
- Condition
- Angina Pectoris
- Intervention (Device)
- Orsiro DES
- Intervention (Device)
- Xience DES
- Lead sponsor
- Biotronik, Inc.
- Collaborator
- Biotronik AG
- Collaborator
- Baim Institute for Clinical Research
- Collaborator
- Medstar Health Research Institute
Record details
- Record id
cardio:ct-nct02389946- Content hash
a1254e491d3fe88679aff21e86043db11abb2e6aa252681085d075100369afdb